Free. Unsubscribe any time.
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. filed 42 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 247 transactions and 1,663,911 shares. None carries the SEC's AFF10B5ONE flag; all 42 name a plan in a footnote. 11 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-10, came 14 days after the one before it (2026-08-27) and reports 10 transactions against 1 in the filing before it.
- The sales it reports total 38,287 shares, 38,007 more than the 280 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 42 filings on file run from 2025-01-08 to 2026-09-10, and state 10 plan adoption dates, from 2023-05-09 to 2026-06-09.
Trades in BeOne Medicines Ltd. 247
- Wang Xiaodong — 2025-01-07 · S · 19,251 shares
- Wang Xiaodong — 2025-01-07 · S · 11,310 shares
- Wang Xiaodong — 2025-01-07 · S · 4,260 shares
- Wang Xiaodong — 2025-01-07 · S · 5,638 shares
- Wang Xiaodong — 2025-01-07 · S · 1,301 shares
- Wang Xiaodong — 2025-02-04 · S · 9,099 shares
- Wang Xiaodong — 2025-02-04 · S · 1,519 shares
- Wang Xiaodong — 2025-02-04 · S · 2,161 shares
- Wang Xiaodong — 2025-02-04 · S · 17,805 shares
- Wang Xiaodong — 2025-02-04 · S · 9,776 shares
- Wang Xiaodong — 2025-02-04 · S · 1,400 shares
- Wu Xiaobin — 2025-02-18 · S · 19,576 shares
Adoption dates in BeOne Medicines Ltd. 10
- 2023-05-09 — stated in 2 filings
- 2024-05-13 — stated in 4 filings
- 2024-06-13 — stated in 4 filings
- 2024-08-12 — stated in 8 filings
- 2025-03-12 — stated in 3 filings
- 2025-05-14 — stated in 10 filings
- 2025-11-07 — stated in 1 filing
- 2026-03-10 — stated in 6 filings
- 2026-05-29 — stated in 3 filings
- 2026-06-09 — stated in 1 filing
Results prints in BeOne Medicines Ltd. 11
- 2025-02-27
- 2025-04-28
- 2025-05-07
- 2025-08-06
- 2025-08-29
- 2025-11-06
- 2026-02-26
- 2026-04-14
- 2026-05-06
- 2026-08-05
- 2026-08-26
Trades before a print in BeOne Medicines Ltd. 2
- 0 days before the 2025-02-27 print — 2025-02-27 · S · Lee Chan Henry · 1,205 shares
- 1 day before the 2026-08-26 print — 2026-08-25 · S · Wu Xiaobin · 280 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Lee Chan Henry · 504 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Lee Chan Henry · 598 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Lee Chan Henry · 100 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 1,327 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 575 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 479 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 437 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 1,782 shares
- 6 days before the 2025-02-27 print — 2025-02-21 · S · Wang Lai · 400 shares
- 6 days before the 2026-04-14 print — 2026-04-08 · S · Lee Chan Henry · 332 shares
Interval to BeOne Medicines Ltd.’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 20within 10 days
- 0shortest, days
- 8no later print
- Wu Xiaobin 2025-02-18 · S · 9 days before the 2025-02-27 print · President, COO & GM China
- Wu Xiaobin 2025-02-18 · S · 9 days before the 2025-02-27 print · President, COO & GM China
- Wu Xiaobin 2025-02-18 · S · 9 days before the 2025-02-27 print · President, COO & GM China
- Wu Xiaobin 2025-02-20 · S · 7 days before the 2025-02-27 print · President, COO & GM China
- Lee Chan Henry 2025-02-21 · S · 6 days before the 2025-02-27 print · SVP, General Counsel
- Lee Chan Henry 2025-02-21 · S · 6 days before the 2025-02-27 print · SVP, General Counsel
- Lee Chan Henry 2025-02-21 · S · 6 days before the 2025-02-27 print · SVP, General Counsel
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Wang Lai 2025-02-21 · S · 6 days before the 2025-02-27 print · Global Head of R&D
- Lee Chan Henry 2025-02-27 · S · 0 days before the 2025-02-27 print · SVP, General Counsel
- Wang Lai 2025-07-29 · S · 8 days before the 2025-08-06 print · Global Head of R&D
- Wang Lai 2025-07-29 · S · 8 days before the 2025-08-06 print · Global Head of R&D
- Wang Lai 2025-07-29 · S · 8 days before the 2025-08-06 print · Global Head of R&D
- Wang Lai 2025-07-30 · S · 7 days before the 2025-08-06 print · Global Head of R&D
- Lee Chan Henry 2026-04-08 · S · 6 days before the 2026-04-14 print · SVP, General Counsel
- Wu Xiaobin 2026-08-25 · S · 1 day before the 2026-08-26 print · President and COO
Adoption dates BeOne Medicines Ltd. states
- 2023-05-09 in 2 filings
- 2024-05-13 in 4 filings
- 2024-06-13 in 4 filings
- 2024-08-12 in 8 filings
- 2025-03-12 in 3 filings
- 2025-05-14 in 10 filings
- 2025-11-07 in 1 filing
- 2026-03-10 in 6 filings
- 2026-05-29 in 3 filings
- 2026-06-09 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 12, 2025”
Reported results dates on file
- 2025-02-27
- 2025-04-28
- 2025-05-07
- 2025-08-06
- 2025-08-29
- 2025-11-06
- 2026-02-26
- 2026-04-14
- 2026-05-06
- 2026-08-05
- 2026-08-26
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.